Financial Architects, Inc Lannett CO Inc Transaction History

Financial Architects, Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 01, 2019	SELL	$3.43 - $6.19 $28,297 - $51,067	-8,250 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$4.75 - $14.5 $39,187 - $119,625	8,250 New	8,250 $39,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.